Cellini M, Possati G L, Puddu P, Caramazza R
Institute of Ophthalmology, University of Bologna, Italy.
Eur J Ophthalmol. 1996 Oct-Dec;6(4):475-7. doi: 10.1177/112067219600600424.
The authors evaluated the efficacy of interferon-alpha used intralesionally in the therapy of low-grade conjunctival non-Hodgkin lymphoma in an HIV-positive patient. The patient received one intralesional injection of 1,000,000 U of interferon-alpha three times a week for a total of twelve doses. The remission of conjunctival involvement was seen three months from the end of therapy. The intralesional use of interferon-alpha can be considered an efficacious therapy for low-grade conjunctival non-Hodgkin lymphoma.
作者评估了病灶内注射α干扰素治疗一名HIV阳性患者低度结膜非霍奇金淋巴瘤的疗效。该患者每周接受3次病灶内注射100万单位α干扰素，共注射12剂。治疗结束3个月后，结膜受累情况出现缓解。病灶内注射α干扰素可被视为治疗低度结膜非霍奇金淋巴瘤的有效疗法。
